DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

RITES Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 59 min ago·7 Oct 2026, 9:39 am

Rites

RITES Limited has informed stock exchanges that it has received a certificate under SEBI Regulation 74(5) of the Depositories and Participants Regulations, 2018. This regulatory filing confirms that the company has successfully completed the process of issuing and allotting shares to its shareholders through the electronic depository system.

This development is a routine administrative milestone for the company. It signifies that the share transfer process is fully compliant with SEBI's regulations and confirms the successful settlement of the allotted shares in demat accounts. For investors, this is a standard procedural update that does not indicate any new business activity or financial performance.

Investors should monitor the company's future quarterly results and order inflows to gauge its operational performance. This regulatory update itself does not carry any immediate market-moving implications, so investors should focus on the company's core business metrics and order book for decision-making.